Page 7 - William Windham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting

As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at one-year follow-up Additional data demonstrated improved preservation of kidney. | June 5, 2023

United statesChristopher degnanZara lockshinWilliam windhamMel sorensenExchange commissionAmerican society of clinical oncologyGalera therapeutics incDrug administrationSolebury strategic communicationsClinical oncologyNew drug applicationGlomerular filtration rateFast trackBreakthrough therapyPrescription drug user fee

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

United statesMel sorensenWilliam windhamZara lockshinChristopher degnanExchange commissionSolebury strategic communicationsGalera therapeutics incAmerican society of clinical oncologyDrug administrationClinical oncologyNew drug applicationGlomerular filtration rateFast trackBreakthrough therapyPrescription drug user fee

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapyMALVERN, Pa., May 18, 2023 Galera Therapeutics, Inc. , a clinical-stage. | June 11, 2023

United statesMel sorensenChristopher degnanWilliam windhamZara lockshinDrug administrationSolebury strategic communicationsExchange commissionGalera therapeutics incNew drug applicationPrescription drug user feeOrphan drug designationPrivate securities litigation reform actBreakthrough therapy designationFast track designationAnnual report

Galera Therapeutics : Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives with decades of experience successfully launching and commercializing new oncology products - Form 8-K

Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives. | May 11, 2023

United statesSan antonioChristopher degnanMel sorensenCarryn andersonLorraine walkerMark bachledaElizabeth cullenWilliam windhamZara lockshinGalera therapeutics incExchange commissionCompany viceOncology nursing societyEuropean congress on headUniversity of iowa

Benitec Biopharma to Present at the JMP Securities Life Sciences Conference

Benitec Biopharma to Present at the JMP Securities Life Sciences Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam windhamSecurities life sciences conference onBenitec or companyBenitec biopharma incExecutive chairmanChief executive officerLife sciences conferenceOculopharyngeal muscular dystrophyRelations contactSolebury strategic communicationsphoneBenitec biopharma